Study of Systemic Impact of Trace Elements Release by Implantable Medical Devices. Identification of Biomarkers of Systemic Inflammation
NCT ID: NCT03812627
Last Updated: 2022-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
159 participants
INTERVENTIONAL
2019-06-24
2021-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immunological-Clinical Evaluation of the Etiopathogenesis of Peri-Implantitis
NCT07012915
Evaluation of the Novel Implant Disease Risk Assessment : a Retrospective Study (IDRA)
NCT04888572
Expression of Epithelial-Mesenchymal Transition Associated Markers in Peri-implant Tissues
NCT05832541
Clinical and Microbiological Outcomes of Dental Implants After 10-22 Years of Function
NCT06803576
Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis
NCT05772078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* to establish the norms of concentrations of free TE and nanoparticles for some forty of elements (in particular Chrome, Cobalt, Nickel, Titanium, Tantalum, Zirconium, Tungsten, Gold, Silver, Mercury, Molybdenum, Strontium ...) in different materials (blood, urine, hair and the viscera), with non-IMD holder subjects, before and after mineralization of these materials (dead patients and autopsied non-IMD holder subjects and subjects before placement of IMD.
* to evaluate the distribution of concentrations of metals in the same materials and in peri-prothetic environment with IMD holder subjects (dead autopsied patients), more often with no inflammatory sign, with possibility of some probably inflammatory IMD.
* to evaluate the parameters of distributions of concentrations of metals in same materials (with the exception of the viscera) with living IMD holder patients, with inflammatory reaction (during revision surgery).
* to define the most suitable material (accessibility, concentrations, absence of contamination) for follow-up and evolution of inflammation in order to determinate norms of studied metals concentration.
* to determinate proportion between different forms of circulation: particulate form (analysis after full mineralization) or free form (analysis without mineralization, permitting measurement of free forms), trace elements in organism.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Re-intervention of hip prosthesis made of ceramic or metal
Re-intervention surgery: blood, urine, hair, synovial fluid and peri-prosthetic tissue collections.
50 patients for re-intervention of hip prosthesis with friction couples of: ceramic-on-ceramic or metal-on-metal
(25 patients by group)
Blood, urine, hair, synovial fluid and peri-prosthetic tissue collections
All inpatient subjects: following samples will be collected during hospitalization:
Twice blood and urine collections:
1. at the beginning of hospitalization: 10 ml of blood + 5 ml of urine;
2. at the end of hospitalization: 5 ml of blood + 5 ml of urine. Synovial fluid collection: 1 ml Peri-prosthetic tissue collection: about 1 cm3 Hair collection: a single hair of 0.5 cm diameter
Re-intervention of hip prosthesis of stainless steel ball
Re-intervention surgery: blood, urine, hair, synovial fluid and peri-prosthetic tissue collections.
50 patients for re-intervention of hip prosthesis of stainless steel ball.
Blood, urine, hair, synovial fluid and peri-prosthetic tissue collections
All inpatient subjects: following samples will be collected during hospitalization:
Twice blood and urine collections:
1. at the beginning of hospitalization: 10 ml of blood + 5 ml of urine;
2. at the end of hospitalization: 5 ml of blood + 5 ml of urine. Synovial fluid collection: 1 ml Peri-prosthetic tissue collection: about 1 cm3 Hair collection: a single hair of 0.5 cm diameter
Re-intervention of knee prosthesis
Re-intervention surgery: blood, urine, hair, synovial fluid and peri-prosthetic tissue collections.
50 inpatient subjects for re-intervention of knee prosthesis polyethylene-on-metal.
Blood, urine, hair, synovial fluid and peri-prosthetic tissue collections
All inpatient subjects: following samples will be collected during hospitalization:
Twice blood and urine collections:
1. at the beginning of hospitalization: 10 ml of blood + 5 ml of urine;
2. at the end of hospitalization: 5 ml of blood + 5 ml of urine. Synovial fluid collection: 1 ml Peri-prosthetic tissue collection: about 1 cm3 Hair collection: a single hair of 0.5 cm diameter
Dead patients IMD holders autopsied
Autopsy: 80 dead patients IMD holders will be autopsied.
Autopsy
Dead patients will be autopsied: hair, urine, blood, peri-prosthetic tissue and viscera (liver, kidney, spleen, brain, heart, lung) sampling for each autopsy.
Dead patients non-IMD holders autopsied
Autopsy: dead patients non-IMD holders autopsied, 30 subjects in this arm.
Autopsy
Dead patients will be autopsied: hair, urine, blood, peri-prosthetic tissue and viscera (liver, kidney, spleen, brain, heart, lung) sampling for each autopsy.
patients before first prosthesis surgery
Before the initial prosthesis surgery: 30 patients Blood, urine, hair, synovial fluid and peri-prosthetic tissue collections will be done
Blood, urine, hair, synovial fluid and peri-prosthetic tissue collections
All inpatient subjects: following samples will be collected during hospitalization:
Twice blood and urine collections:
1. at the beginning of hospitalization: 10 ml of blood + 5 ml of urine;
2. at the end of hospitalization: 5 ml of blood + 5 ml of urine. Synovial fluid collection: 1 ml Peri-prosthetic tissue collection: about 1 cm3 Hair collection: a single hair of 0.5 cm diameter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood, urine, hair, synovial fluid and peri-prosthetic tissue collections
All inpatient subjects: following samples will be collected during hospitalization:
Twice blood and urine collections:
1. at the beginning of hospitalization: 10 ml of blood + 5 ml of urine;
2. at the end of hospitalization: 5 ml of blood + 5 ml of urine. Synovial fluid collection: 1 ml Peri-prosthetic tissue collection: about 1 cm3 Hair collection: a single hair of 0.5 cm diameter
Autopsy
Dead patients will be autopsied: hair, urine, blood, peri-prosthetic tissue and viscera (liver, kidney, spleen, brain, heart, lung) sampling for each autopsy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Autopsied patients with and without IMD;
* Covered by a health insurance.
Exclusion Criteria
* Professional exposure to metals;
* Patient under guardianship.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Claude Alvarez, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Laboratoire de Pharmacologie-Toxicologie, Hôpital Raymond Poincaré, Garches
Thomas BAUER, MD, PhD
Role: STUDY_DIRECTOR
Orthopédie et traumatologie, Hôpital Ambroise Paré, Boulogne-Billancourt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Chirurgie orthopédique, Hôpital Raymond Poincaré
Garches, Hauts-des-Seine, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP180539
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.